We are live on ! Find out more
GP

GLG Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 21.14%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+21.14%
3 Year Est. Return
+49.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.14B
AUM Growth
+$251M
Cap. Flow
-$130M
Cap. Flow %
-6.09%
Top 10 Hldgs %
20.07%
Holding
564
New
243
Increased
78
Reduced
76
Closed
91

Top Buys

Rank Stock Value
1
AAAP
Advanced Accelerator Applications S.A.
AAAP
+$46.8M
2
NXPI icon
NXP Semiconductors
NXPI
+$35M
3
MON
Monsanto Co
MON
+$29.2M
4
CYOU
Changyou.com Limited American Depositary Share
CYOU
+$22.9M
5
DELL icon
Dell
DELL
+$22.8M

Top Sells

Rank Stock Value
1
SCLN
Sciclone Pharmaceuticals Inc
SCLN
+$29M
2
RICE
Rice Energy Inc.
RICE
+$23M
3
CRTO icon
Criteo S.A.
CRTO
+$22.5M
4
BCR
CR Bard Inc.
BCR
+$18M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$15.8M

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.22%
2 Consumer Discretionary 13.47%
3 Technology 9.7%
4 Financials 9.51%
5 Industrials 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DGX icon
326
Quest Diagnostics
DGX
$26.2B
$162K 0.01%
+1,645
New +$156K
DHR icon
327
Danaher
DHR
$146B
$159K 0.01%
+1,933
New +$157K
CTSO icon
328
Cytosorbents Corp
CTSO
$22M
$156K 0.01%
+24,047
New +$153K
CSRA
329
DELISTED
CSRA Inc.
CSRA
$154K 0.01%
5,160
– –
HP icon
330
Helmerich & Payne
HP
$4.43B
$153K 0.01%
+2,360
New +$132K
ALNY icon
331
Alnylam Pharmaceuticals
ALNY
$35.6B
$152K 0.01%
+1,200
New +$151K
PSEC icon
332
Prospect Capital
PSEC
$1.14B
$152K 0.01%
+22,600
New +$147K
TYME
333
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$152K 0.01%
+23,820
New +$106K
ADM icon
334
Archer Daniels Midland
ADM
$40.8B
$151K 0.01%
+3,775
New +$155K
AIG icon
335
American International
AIG
$39.8B
$150K 0.01%
+2,524
New +$155K
O icon
336
Realty Income
O
$58B
$150K 0.01%
+2,713
New +$147K
HII icon
337
Huntington Ingalls Industries
HII
$11.3B
$141K 0.01%
600
-900
-60% -$212K
COST icon
338
Costco
COST
$406B
$140K 0.01%
+752
New +$130K
FTNT icon
339
Fortinet
FTNT
$115B
$131K 0.01%
15,000
-4,430
-23% -$36.1K
SAIC icon
340
Saic
SAIC
$5.31B
$130K 0.01%
1,700
-366
-18% -$26.5K
CLVS
341
DELISTED
Clovis Oncology, Inc.
CLVS
$128K 0.01%
1,886
-347
-16% -$24.3K
ARWR icon
342
Arrowhead Research
ARWR
$12.2B
$118K 0.01%
+31,974
New +$119K
ACAD icon
343
Acadia Pharmaceuticals
ACAD
$4.83B
$114K 0.01%
+3,794
New +$121K
BAH icon
344
Booz Allen Hamilton
BAH
$8.76B
$114K 0.01%
3,000
-3,000
-50% -$113K
XRAY icon
345
Dentsply Sirona
XRAY
$2.27B
$114K 0.01%
+1,737
New +$110K
TFC icon
346
Truist Financial
TFC
$63.1B
$113K 0.01%
+2,269
New +$110K
GLW icon
347
Corning
GLW
$133B
$109K 0.01%
3,400
+347
+11% +$10.9K
USB icon
348
US Bancorp
USB
$98.7B
$107K 0.01%
+2,004
New +$108K
EXC icon
349
Exelon
EXC
$45B
$106K 0.01%
+3,767
New +$108K
MRK icon
350
Merck
MRK
$371B
$105K ﹤0.01%
+1,952
New +$108K
12 13
14
15 16

Similar funds

IH
IFC Holdings Tampa, Florida $1.45B AUM 15.5% 1-Year Est. Return
GL
GLG LLC New York $1.39B AUM 24.01% 1-Year Est. Return
TAM
TPH Asset Management Houston, Texas $1.01B AUM 2.1% 1-Year Est. Return
SI
SII Investments Appleton, Wisconsin $965M AUM 15.44% 1-Year Est. Return
GES
GO ETF Solutions London, United Kingdom $689M AUM 29.59% 1-Year Est. Return
AS
Acorns Securities Irvine, California $660M AUM
QAM
Quentec Asset Management New York $634M AUM 22.87% 1-Year Est. Return
BTIS
BB&T Investment Services Charlotte, North Carolina $595M AUM 15.92% 1-Year Est. Return

GLG Partners's Q4 2017 Portfolio in Review

As of Q4 2017, GLG Partners held 564 positions worth $2.14B, up 13% from $1.89B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

GLG Partners withdrew a net $130M in Q4 2017, closing 91 positions and reducing 76 holdings. Its most notable exit was Sciclone Pharmaceuticals Inc, an estimated $29M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, GLG Partners opened a new position in Advanced Accelerator Applications S.A. worth $49.2M.

  • GLG Partners's largest Q4 2017 buy was Advanced Accelerator Applications S.A.: 603,055 shares worth $49.2M.
  • GLG Partners added most to NXP Semiconductors in Q4 2017, an estimated $35M increase.
  • GLG Partners's biggest Q4 2017 reduction was Criteo S.A., cutting an estimated $22.5M.
  • GLG Partners fully exited Sciclone Pharmaceuticals Inc in Q4 2017, selling an estimated $29M.
  • GLG Partners's ten largest holdings make up 20% of its $2.14B portfolio in Q4 2017.
  • GLG Partners opened 243 new positions and closed 91 in Q4 2017.
  • GLG Partners's portfolio value rose 13% quarter-over-quarter to $2.14B.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.